Nanobiotix (NBTX) Payables (2019 - 2025)
Historic Payables for Nanobiotix (NBTX) over the last 7 years, with Q2 2025 value amounting to $13.2 million.
- Nanobiotix's Payables fell 3607.7% to $13.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $13.2 million, marking a year-over-year decrease of 3607.7%. This contributed to the annual value of $21.7 million for FY2024, which is 992.76% up from last year.
- Latest data reveals that Nanobiotix reported Payables of $13.2 million as of Q2 2025, which was down 3607.7% from $21.4 million recorded in Q4 2024.
- Nanobiotix's 5-year Payables high stood at $21.4 million for Q4 2024, and its period low was $9.8 million during Q4 2022.
- For the 5-year period, Nanobiotix's Payables averaged around $15.4 million, with its median value being $15.7 million (2023).
- As far as peak fluctuations go, Nanobiotix's Payables soared by 9990.14% in 2023, and later plummeted by 3607.7% in 2025.
- Over the past 5 years, Nanobiotix's Payables (Quarter) stood at $10.6 million in 2021, then dropped by 7.51% to $9.8 million in 2022, then soared by 99.9% to $19.6 million in 2023, then rose by 9.11% to $21.4 million in 2024, then plummeted by 38.46% to $13.2 million in 2025.
- Its Payables was $13.2 million in Q2 2025, compared to $21.4 million in Q4 2024 and $20.6 million in Q2 2024.